$1.82
In chiusura: Nov 17, 4:00 PM EST

NervGen Pharma (NGEN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $-0.04 | $0.01 | -520.0 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $0.01 | — |
| Actual | $-0.04 | $-0.27 |
| Surprise | -520.0% | — |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.10 | $-0.13 | $-0.14 |
| Revenue | |||
| Consensus | — | — | — |